EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology

Qiuyan Xu iD, Li Shen, Lei Hong, Xiang Li, Min Lu, Shuangqin Ran

Infection and Drug Resistance · 2026-09 · Volume 19 · 1-14

DOI: 10.2147/idr.s622829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-09. Verfasst von Qiuyan Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzho…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mycoplasma pneumoniae pneumonia (MPP) is a common cause of community-acquired pneumonia in children, yet its metabolic alterations and pathogenic mechanisms remain incompletely understood. This study aimed to characterize the plasma metabolomic profile of children with MPP and explore associated metabolic pathways.

Methods

This retrospective case-control study involved 42 children including 14 MPP patients, 14 non-MPP (MPN) patients, and 14 healthy controls (HC). Clinical and laboratory data were compared across groups. Plasma metabolomic profiling was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Multivariate statistical analyses, including principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), and orthogonal partial least squares-discriminant analysis (OPLS-DA), were employed to identify metabolic differences among groups. Pathway enrichment analysis used the KEGG and Reactome databases.

Results

Clinically, the MPP group exhibited significantly higher C-reactive protein (CRP) levels and neutrophil percentages, and lower lymphocyte percentages (all P

Schlagwörter

Stichwörter der Autor:innen

Mycoplasma pneumoniae pneumoniacandidate metabolic biomarkerschildrenpathogenesisuntargeted metabolomics

Autor:innen und Institutionen

  • Department of Pediatrics, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.
  • Department of Pharmacy, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.
  • Institute of Clinical Medicine Research, Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, People's Republic of China.

ORCID-Profile: Qiuyan Xu

Zitieren

APA

Xu, Q., Shen, L., Hong, L., Li, X., Lu, M., & Ran, S. (2026). Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology. Infection and Drug Resistance, Volume 19, 1-14. https://doi.org/10.2147/idr.s622829

Vancouver

Xu Q, Shen L, Hong L, Li X, Lu M, Ran S. Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology. Infection and Drug Resistance. 2026;Volume 19:1-14. doi:10.2147/idr.s622829

BibTeX
@article{Xu2026,
  author = {Xu, Qiuyan and Shen, Li and Hong, Lei and Li, Xiang and Lu, Min and Ran, Shuangqin},
  title = {Analysis of Plasma Biomarkers and Potential Pathogenesis in Children with Mycoplasma pneumoniae Pneumonia Based on Metabolomic Technology},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--14},
  doi = {10.2147/idr.s622829}
}
Kostenlos starten →